INTRODUCTION {#sec1}
============

Although human genomes are about 99.9% identical, the remaining 0.1% is the reason of difference between people caused by different variants. Since 2003, the complete sequence of human genome, its annotation and increased advancement of sequencing technologies (i. e., Sanger and Next-generation- sequencing; NGS) have provided all the necessary conditions for the identification of all variants in human coding and non-coding sequence (1, 2). Although the technique for variant detection is now becoming a routine, the key question throughout many years concerns the function of detected variants. The resource of important information about functional genomics are several large-scale projects, for instance, the ENCODE project, the main goal of which was to identify all the functional elements, including regulatory elements in both coding and non-coding regions(3). According to another, the 1000 Genomes Project, there are about 20,000-- 23,000 variants in synonymous and nonsynonymous regions of the human genome. Even though not all of them are functionally meaningful, 530--610 of the variants have functional impact by causing inframe deletions and insertions, premature stop codons, frameshifts, or by disrupting splice sites (4). Despite numerous studies, scientists are still facing a huge challenge in unravelling what the sequence means and in deciding whether or not a found variant is pathogenic. A pathogenic variant can lead to disease or cause a number of disorders. However, understanding of pathogenic mechanisms creates an opportunity to prevent severe consequences by developing novel diagnostic tools and by designing highly effective treatments for the disease (5, 6). To achieve this aim it is necessary to perform large-scale functional genome analysis that involves different fields of study: genomics, epigenomics, transcriptomics, proteomics, and interactomics. In order to describe the functions of genes and proteins as well as to research the relationship between the genotype and the phenotype, a large number of various methods, including model systems (e. g., CRISPR-Cas9), can be used (6--8). However, every method has its advantages and disadvantages (they are summarized in the [Table](#T1){ref-type="table"}). For this reason, the present paper aims to give a brief overview of the most common technologies and tools that could be applied for functional genome analysis, mainly of transcriptome.

FROM VARIANT DETECTION TO FUNCTIONAL GENOME ANALYSIS {#sec2}
====================================================

Variants in coding as well as non-coding genome sequence range from single nucleotide changes to large, microscopically visible, chromosomal aberration. These variants may have a huge impact on the function of gene. They can be either beneficial (e. g., single nucleotide polymorphism; SNP) with no negative effect on the phenotype, or pathogenic (e. g., nonsense variant) -- resulting in a number of different disorders and diseases (9, 10). Depending on the variant type and locus, there are numerous different genetic methods and tools for the variant detection. For example, due to its simplicity the most frequent method for the analysis of a large (\>5 Mb) chromosomal aberration is karyotype analysis by using the GTG banding technique (11). Other molecular genetic methods, such as microarray-based comparative genomic hybridization (aCGH) or fluorescent *in situ* hybridization (FISH), should be applied for a more accurate analysis. However, these methods have some significant limitations: the aCGH does not detect mosaicism, balanced translocations and inversions, while the FISH requires specific probes (12, 13). Moreover, for particular variant detection another molecular genetic methods might be applicable, which include restriction enzyme assay, Multiplex ligation-dependent probe amplification (MLPA), even though many of the tests are based on the Polymerase chain reaction (PCR) and its variants (e. g., multiplex PCR) (14).

Although researchers can easily plan their assay in the case of particular variants, they are facing some challenges in the study of unspecified variants (6). Sequencing is considered to be the "gold standard" method for the identification of known as well as unspecified variants in the genomic DNA. In accordance with the previous statement, the Sanger or Next-Generation Sequencing (NGS) techniques can be used (15, 16). The concept behind these two methods is similar. During the polymerase chain reaction, which consists of several cycles of sequential DNA replication, DNA polymerase catalyzes the complementary incorporation of fluorescently-labeled deoxyribonucleoside 5'-triphosphates (dNTPs) into the DNA template. For each cycle, a colour of the labeled DNA fragment is recorded by a detector, thus determining nucleotide in the sequence. The main difference between the conventional (i. e., Sanger) technology and the NGS is that the latter is not limited to a single DNA fragment but analyzes millions of fragments in massively parallel sequencing technology (17, 18). These two sequencing methods are widely used all over the world. Even so, it is considered that in a small-scale project it is more eligible to use the Sanger sequencing system because of its accuracy. On the other hand, in large-scale projects this research method would be expensive and time-consuming, therefore the NGS needs to be applied (19, 20). General progress in technology achieved in some strategies of the next-generation DNA sequencing has a huge impact on genetic research (2). Recently, the most widely used platforms have been Roche/454 Life Science, Applied Biosystems SOLiD, and Illumina Genome Analyzer. Another DNA sequencing technology has been lately developed by Ion Torrent. Nevertheless, "sequencing- by-synthesis" used by Illumina currently is one of the most popular NGS platform. First of all, a randomly fragmented DNA is ligated with specific adaptors and amplified by the use of PCR. Secondly, a performed DNA library should be immobilized on the beads or arrays, thus generating clusters of identical DNA fragments. These clusters are then read by sequential cycles of nucleotide incorporation, washing, and detection, where the number of the cycles eventually determines the read length (7, 19--21). In order to understand the genome structure, function, or evolution, it is not enough to obtain the DNA sequencing data through the NGS: but there is also a need for deep and precise analysis using bioinformatics approaches. The key path to successful sequence analysis is to align the sequence of interest with another sequence whose function is known (usually termed as the reference genome). It might be very useful when the gene function is unknown but is evolutionary related to another gene whose function is defined. In such a case, it can be suspected that the unknown gene has the same or similar function. Furthermore, the sequences might be scanned in order to find the significant matches between the components of a sequence that have been previously described as having a huge impact on the genomics function (6, 22). In order to compare the data, it is necessary to search for information in different biomedical databases. One of the biggest sources of biomedical and genomic information is the NCBI (National Center for Biotechnology Information), which provides access to other databases such as PubMed, Entrez Gene, OMIM, Variation Viewer, dbSNP, and others (23).

EPIGENOMICS {#sec3}
===========

For functional analysis, it is important to take epigenetic modifications such as DNA methylation and histone modifications into account, because they affect gene expression without any changes in the underlying DNA sequence (24). DNA methylation, which usually occurs in the context of densely situated CpG dinucleotides (i. e., CpG islands), correlates with transcriptional suppression. In order to detect DNA methylation status, unmethylated cytosines are converted into uracil by using sodium bisulfite, because methylated cytosine is resistant to this impact. Additionally, methylation-dependent restriction enzymes (MDRE) are highly effective for DNA methylation analysis. These enzymes, e. g., *HpaII* and *MspI*, recognize and simply digest the methylated DNA. Usually, MDRE or even more frequently used bisulfite conversion is the first step for many subsequent methods such as methylation-specific PCR, sequencing, bead array, etc. (25--28).

Histone modifications -- acetylation, phosphorylation, methylation, ubiquitination, and others -- are another cause of epigenetically-regulated genes. Depending on the modification type and locus, gene expression can be either activated or repressed (29). The most common method for the investigation of histone modifications is chromatin immunoprecipitation (ChIP) based on the interaction between the antigen (of associated with DNA target protein) and the antibody (specific to target modified protein). After the precipitation, the genomic DNA is released for further research hinged on microarray analysis (ChIPchip), sequencing (ChIP-seq), or quantitative PCR. Although these methods are high-throughput, the dependence on a specific antibody sometimes limits the use of the ChIP (21, 30).

TRANSCRIPTOMICS {#sec4}
===============

When the human genome was fully sequenced, the focus of attention shifted towards identifying and annotating its functional DNA elements, including those that regulate gene expression. Identification of such elements is a vitally important step towards elucidating pathogenic pathways that affect human health (3, 6).

All the RNA-level processes, including transcription activation or inhibition, mRNA processing, and its transport are regulated by different functional elements of the genomic DNA. Nevertheless, the highest regulation occurs at the transcriptional initiation level through several regulative elements, which are called the *cis*-acting regulatory sequence and *trans*-factors (6, 31). *Trans*-factors such as transcription factors (TF), activators, and repressors (including co-activators and co-repressors) interact with specific DNA regions, i. e., *cis*-acting regulatory sequence that includes core promoter (with a TATA box and other binding elements), proximal promoter, enhancer, silencer, insulator, and locus control region (LCR). Investigation of these regulatory elements may be a challenge for the scientists because of the difficulties in identifying the position of transcription start sites (TSSs) and transcription factors binding sites (TFBSs) in the core promoter. However, there are several experimental and bioinformatical approaches (31). First of all, a comparative bioinformatical approach is necessary for the study of the regulatory elements. This type of research is usually based on constructing alignments between orthologous sequences because sequence homology provides valuable evidences to gene function analysis (6, 32). Nevertheless, a deeper understanding of regulatory elements requires laboratory investigations. It is believed that every TFBS could be detected by the above-mentioned ChIP method. Theoretically, depending on immunoprecipitation of the target protein, the core promoters, enhancers, silencers, insulators and LCRs could be determined (31). Furthermore, epigenetic markers can be helpful in detecting TSSs in the core promoter and enhancer loci, because TSSs of actively transcribed genes are marked by H3K4me3 and H3K27ac, while enhancers by H3K4me1 and H3K27ac (33). Another very frequent functional assay of the regulatory element is based on the transgenesis of a specific reporter- gene (e. g., the gene of the green fluorescent protein -- GFP or luciferase) into the target regulatory sequence. After the translation, activity of the reporter-gene is measured, e. g., by fluorescence of the GFP, with the purpose to determine if the examined region contains elements that alter reporter-gene expression (31, 32).

Substantial information about functional genomics can be obtained through the analysis of the messenger RNA (mRNR) or cDNA, which is copied from the mRNA by reverse transcription PCR. Therefore researchers often choose to test the mRNR or cDNA rather than DNA, because RNA analysis may be more eligible for a gene that has many small exons and it can also reveal abnormal splicing (6). For many years there have been some standard methods for measuring the mRNR expression: Northern blotting, serial analysis of gene expression (SAGE) as well as quantitative real-time PCR (qPCR) among them. The SAGE method is based on the conversion of an RNA molecule into a short unique tag, while Northern blotting -- on hybridization with radioactive probe. This allows to perform quantitative analysis by counting the number of tags and measuring intensity of band, respectively. However, both these methods are characterized as low-throughput (34, 35). Nevertheless, for the mRNA quantitation and gene expression evaluation the "gold standard" is qPCR, which is fast, very sensitive, and highly reproducible. The principle of this method is that during the reverse transcriptional reaction, complementary single-stranded cDNA from the RNA template is synthesized. The cDNA is necessary for subsequent use in quantitative PCR (36). The aim of this reaction is to measure fluorescence intensity that is directly proportional to the amount of cDNA in the sample (37). There are two strategies for qPCR data analysis: absolute quantification (based on the calibration curve) and relative quantification (based on the comparison with reference sample) (38). For the relative gene expression level calculation, the most convenient way is comparative *CT* (or 2-^ΔΔ*CT*^) method. This method relies on comparing the CT values of the target and reference samples, using a reference (endogenous housekeeping) gene as the normalizer. Finally, the method results in the fold change of target gene expression relative to a reference sample, normalized to a housekeeping gene (39).

Acceleration of high-throughput technologies such as cDNA microarray and RNA sequencing (RNA-seq), which also provides the possibility of transcriptional characterization, very often replaces preceding methods (40, 41). Results obtained by a cDNA microarray assay provide important genome- wide information about the changes of gene expression in various cell lines and in different stages of development. This method is based on hybridization of fluorescently labelled cDNA with the particular oligonucleotides (probe) on the specific microarray. The amount of hybridization recorded for a specific probe is proportional to the number of DNA fragments in the sample. In this way, the obtained absolute hybridization values give an opportunity to detect genetic variation in the human genome (41, 42). Despite the great advantages of cDNA microarray, high-throughput RNA sequencing based on different NGS systems is also increasingly used. The RNA sequencing results in a number of short reads. Aligned to a reference genome, they produce a specific transcription map that corresponds to the transcriptional structure and gene expression level (43). It means that this technique is appropriate for gene, transcripts (including alternative gene spliced transcripts), or allele-specific expression identification. Moreover, it is possible to accurately measure translation of transcripts. As each method has both advantages and disadvantages, the last one is not an exception. The problems in RNA-seq are often related with high sequence similarity between alternative spliced isoforms or difficulties in data analysis (44, 45).

PROTEOMICS AND INTERACTOMICS {#sec5}
============================

From the functional point of view, analysis of proteomics and interactomics is as vitally important as previously described analysis of genomics, epigenomics, and transcriptomics, because some studies show that gene expression at DNA or mRNA levels is substantially unchanged, although it affects the protein function and vice versa (46, 47). Proteins perform a vast array of functions within organisms, though abnormal protein expression that occurs due to post-transcriptional modifications or protein interaction with another protein or nucleic acids disrupts cell function (48).

Depending on the intent of the experiment, there are two well-known strategies for protein quantification: immunoassays or antibody-free detection methods. Immunoassay, such as the enzyme-linked immunosorbent assay (ELISA), is a widely-used method due to its high sensitivity and strong specificity (49). However, sometimes researchers can face the problem when no antibody exists for the protein of interest. In such cases the solution is antibody-free methods. Firstly, compared to one-dimensional protein separation method, two-dimensional gel electrophoresis (2- DE), which separates protein by two properties in 2D gels is more effective (50, 51). However, the most common and comprehensive analytical tool for protein detection, identification, and quantification is mass spectrometry (MS) that measures mass-to-charge (*m/z*) ratio of ions. Advancement of MS gives an opportunity to achieve a greater throughput of samples with high accuracy and precision. Additionally, it is considered that MS methodology is rapid and reliable for large-scale studies (52--54). Furthermore, due to its advantages MS is very often combined with another technique. For instance, some studies consist of antibody-based purification and mass spectrometry analysis termed mass spectrometric immunoassay (MSIA) (55).

An important step towards characterization of the protein function is the identification of the protein interaction network consisting of different proteins. The most frequent system for detection of interacting proteins in living yeast cells is the two-hybrid system (Y2H). The aim of such investigation is to create genetically modified yeast strains on a selective medium. In such a system, two interacting proteins bound to specific domains switch on polymerase II, which subsequently activate the transcription of a reporter gene, whose transcription leads to a specific phenotype (e. g., changed colour) (56). Furthermore, proteins interact also with nucleic acids, DNA and RNA. In functional approach, the most important interactions are between DNA and transcription factors or regulatory elements. In the case of RNA, it is necessary to test interactions between this nucleic acid and ribosome, or other RNA binding proteins. The analysis of both DNA-protein and RNA-protein interactions is based on similar techniques (57, 58). Previously mentioned high-throughput immunoprecipitation of the nucleic acid and protein complex is increasingly becoming the method of choice for the detection of TFBSs and histone modification. Subsequent microarray, or NGS analysis, enables the identification of a particular locus, i. e., the region that is specifically interacting with the protein of interest. However, the main limitation of the ChIP method is the dependence on antibody specificity (59).

FUNCTIONAL GENOMICS INTEGRATING MODEL SYSTEMS {#sec6}
=============================================

Nowadays, by the use of high-throughput sequencing technologies it is possible to generate detailed catalogue of genetic variation. However, the main question concerns the relationship between the geno-type and phenotype. In order to answer this question, it is not possible to perform functional research directly on human beings due to some bioethical aspects. So there should be applied experimental studies of model systems such as *in vitro* cell culture or animal models for functional interpretation of genome sequence variants (60).

Animal models have long been applied in different studies for the investigation of biological and pathogenical mechanisms, as well as for the development of effective treatment. Depending on the purpose of study, different animal models can be used, although the mouse (*Mus musculus*), the fruit fly (*Drosophila melanogaster*), and the zebrafish (*Danio rerio*) are the most commonly used in functional genome studies. This study has numerous advantages. For example, mutation can be induced artificially and the mutant phenotype can be recognized easily, genes can be cloned using standard procedures, the animal produces a large number of offspring in a relatively short period of time (61). There are two main strategies of using animal model: "knock out" -- suppression of the gene of interest, "knock in" -- incorporation of the same mutation that is observed in a human. For instance, a number of studies have been conducted for creating animal models of human diseases by chemical mutagenesis (e. g., *N*-ethyl nitroso- urea; ENU) that causes random allelic point mutations in mice. However, the major limitation of animal models is the phenotype that often does not reflect human beings (62, 63).

At this very moment, a promising technology for obtaining more information about human diseases is the CRISPR-Cas9 (Clustered Regularly Interspaced Short Polindromic Repeats/ CRISPR-associated) system, which was found to be a prokaryotic immune system against viruses. This system consists of a small cluster of *cas* genes (encoding CRISPR associated proteins) and specific DNA sequence, called CRISPR locus, which comprises short repeats that are separated by unique spacers (64). During a virus infection, its unique spacer integrates into the bacterial CRISPR locus. Subsequently, this locus is transcribed into precursor CRISPR RNA (pre-crRNA). After the processing, the mature crRNA can recognize and destroy target nucleic acid by interacting with Cas proteins (65). So CRISPR locus contains information about previous virus infections, thus giving an opportunity for bacteria to recognize and inactivate the virus in case of re-infection. Currently, some scientific studies show that it is possible to engineer the protein and RNA components of bacterial CRISPR system in order to recognize and cut DNA at the desired locus (66). Due to these properties, there is a possibility of applying this system *in vitro* in the human cell line, in order to study human diseases without any negative consequences (67).

CONCLUSIONS {#sec7}
===========

It is believed that successful functional genome analysis discovers genetic basic for human health by filling the gaps in knowledge about pathogenic pathways between genes, proteins, and their interaction network. There are a lot of different methods and tools for accurate functional analysis. Despite huge analytical progress, these methods have certain limitations (see the [Table](#T1){ref-type="table"}). Thus, in order to extend the limits of current techniques, some high-throughput technologies such as quantitative real-time polymerase chain reaction, next-generation sequencing or mass spectrometry have been developed, which provide an opportunity to perform genome-wide functional analysis. Furthermore, model systems such as CRISPR-Cas9 or animal models are required for an extensive functional interpretation of genome sequence variants. However, in processing large amounts of data researchers are still facing the problem, that usually is very complicated and time consuming. For this reason, there is a need of continuous improvement in technology and development of more efficient analytical tools. It should be noted that for more comprehensive results it is essential to use complex methodologies that complement each other's shortcomings.

###### 

Summary of the main advantages and limitations of the most common technologies used for functional genome analysis

  Technique                                          Advantages                                                                                                                                                                                                                                         Disadvantages                                                                                                                                References
  -------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- ------------
  Variants detection methods                                                                                                                                                                                                                                                                                                                                                                                                                         
  **GTG banding**                                    Effortless of the chromosome number and structure, including balanced rearrangements                                                                                                                                                               Low sensitivity and resolution (5--10 Mb)                                                                                                    (11--13)
  **FISH**                                           Detection of minor structural cytogenetic abnormalities High sensitivity and specificity                                                                                                                                                           Based on probes annealing to specific target                                                                                                 
  **aCGH**                                           Inappropriate for the detection of balanced chromosomal rearrangements                                                                                                                                                                                                                                                                                                                          
  **Sanger**                                         High, quality and reproducibility Does not require a priori knowledge about genomic features Requires low amount of DNA/RNA as input                                                                                                               Time consuming for large-scale projects                                                                                                      (2, 19)
  **NGS**                                            Expensive equipment. Complicated data analysis in the case of unspecified variants                                                                                                                                                                                                                                                                                                              
  **Epigenomics**                                                                                                                                                                                                                                                                                                                                                                                                                                    
  **Bisulfite conversion**                           Resolution at DNA level. Effective method providing information about cytosine methylation                                                                                                                                                         Impossible to distinguish methylated and hemimethylated cytosine                                                                             (26--28)
  **MDRE**                                           Easy to use Availability and assortment of endonucleases                                                                                                                                                                                           DNA methylation assay is circumscribed by the use of a particular enzyme                                                                     \(28\)
  **ChIP** (including **ChIP-chip**, **ChIP-seq**)   Fast well-studied. Compatible with array-or sequencing-based analysis, i. e., it is possible to perform genome-wide analysis                                                                                                                       Relies on antibody specificity Microarray assay relies on particular probes                                                                  \(21\)
  **Transcriptomics**                                                                                                                                                                                                                                                                                                                                                                                                                                
  **Northern Blot**                                  Quantitative and inexpensive method. No specialized equipment is needed There is a possibility of accurate display of the size and amounts of small RNA                                                                                            Radioactive probes Lower sensitivity and lower throughput                                                                                    \(34\)
  **SAGE**                                           Direct and quantitative method. *A priori* knowledge about the gene sequences is not required. SAGE library requires a small amount of RNA as input. Simple data analysis                                                                          Low-throughput                                                                                                                               \(35\)
  **qPCR**                                           Fast, accurate, sensitive and highly reproducible method for mRNA quantification. Ability to detect the amount of mRNR in real time                                                                                                                The risk of bias                                                                                                                             (36--38)
  **cDNA microarray**                                Well-studied,-throughput and quantitative method Based on fluorescence (no need of radioactive probes)                                                                                                                                             Complicated data analysis                                                                                                                    (39, 40)
  **RNA-Seq**                                        Direct, quantitative and high throughput method. Does not require a priori knowledge about the genomic features. Appropriate for gene, transcripts (including alternative gene spliced transcripts) or allele-specific expression identification   High sequence similarity between alternative spliced isoforms                                                                                (21, 42)
  **Transgenesis of reporter gene**                  "Gold standard" and accurate method for functional analysis of regulatory elements. Gene expression is easily detectable by fluorescence                                                                                                           Regulatory elements are widely dispersed through the genome that may cause some difficulties in detection                                    (31, 32)
  **Proteomics and interactomics**                                                                                                                                                                                                                                                                                                                                                                                                                   
  **ELISA**                                          High and specificity                                                                                                                                                                                                                               Relies on antibody specificity                                                                                                               \(47\)
  **2-DE**                                           Efficiently separates proteins by two properties                                                                                                                                                                                                   Poor separation of highly hydrophobic proteins. Inability to analyze very large or very small proteins                                       (48, 49)
  **MS**                                             High-throughput method that rightly identifies and quantifies proteins                                                                                                                                                                             The sample should be high-quality and homogenous Sometimes dissociation efficiency of complex protein is lower                               (50, 52)
  **Y2H**                                            The two-hybrid technique is relatively simple. Appropriate for the first step in identifying interacting protein partners                                                                                                                          The rate of false positive results is relatively high.The need of confirmatory test. Impossible interaction between two proteins at a time   \(7\)
  **Model systems**                                                                                                                                                                                                                                                                                                                                                                                                                                  
  **Chemical mutagenesis**(in animal model)          Mutation can be induced artificially and mutant phenotype can be recognized easily Genes can be cloned using standard procedures                                                                                                                   Phenotype always reflects human beings                                                                                                       (61--63)
  **CRISPR-Cas9**                                    The possibility to engineer the protein and RNA components of bacterial CRISPR system in order to recognize and cut DNA at desired locus                                                                                                           Work requires highly sterile conditions                                                                                                      \(66\)
